Literature DB >> 20072111

Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients.

Cindy X Huang1, Hocine Tighiouart, Srinivasan Beddhu, Alfred K Cheung, Johanna T Dwyer, Garabed Eknoyan, Gerald J Beck, Andrew S Levey, Mark J Sarnak.   

Abstract

A higher body mass index is associated with better outcomes in hemodialysis patients; however, this index does not differentiate between fat and muscle mass. In order to clarify this, we examined the relationship between measures of fat and muscle mass and mortality in 1709 patients from the Hemodialysis Study. Triceps skin-fold thickness was used to assess body fat and mid-arm muscle circumference was used to assess muscle mass. Cox regression was used to evaluate the relationship between measures of body composition with all-cause mortality after adjustments for demographic, cardiovascular, dialysis, and nutrition-related risk factors. During a median follow-up of 2.5 years, there were 802 deaths. In adjusted models with continuous covariates, higher triceps skin-fold thickness and higher body mass index were significantly associated with decreased hazards of mortality, while higher mid-arm muscle circumference showed a trend toward decreased mortality. In adjusted models, lower quartiles of triceps skin-fold thickness, mid-arm muscle circumference, and body mass index were all significantly associated with higher all-cause mortality. These studies show that body composition in end-stage renal disease bears a complex relationship to all-cause mortality.

Entities:  

Mesh:

Year:  2010        PMID: 20072111      PMCID: PMC3155769          DOI: 10.1038/ki.2009.524

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  34 in total

1.  Comparison of three methods for the determination of body fat in patients on long-term hemodialysis therapy.

Authors:  Maria Ayako Kamimura; Nelma Scheyla José Dos Santos; Carla Maria Avesani; Maria Eugênia Fernandes Canziani; Sérgio Antônio Draibe; Lilian Cuppari
Journal:  J Am Diet Assoc       Date:  2003-02

2.  Effects of body size and body composition on survival in hemodialysis patients.

Authors:  Srinivasan Beddhu; Lisa M Pappas; Nirupama Ramkumar; Matthew Samore
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

3.  Comparison of skinfold thicknesses and bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body fat in patients on long-term haemodialysis therapy.

Authors:  Maria Ayako Kamimura; Carla Maria Avesani; Miguel Cendoroglo; Maria Eugênia Fernandes Canziani; Sérgio Antônio Draibe; Lilian Cuppari
Journal:  Nephrol Dial Transplant       Date:  2003-01       Impact factor: 5.992

4.  Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  S F Leavey; K McCullough; E Hecking; D Goodkin; F K Port; E W Young
Journal:  Nephrol Dial Transplant       Date:  2001-12       Impact factor: 5.992

5.  A central body fat distribution is related to renal function impairment, even in lean subjects.

Authors:  Sara-Joan Pinto-Sietsma; Gerjan Navis; Wilbert M T Janssen; Dick de Zeeuw; Reinhold O B Gans; Paul E de Jong
Journal:  Am J Kidney Dis       Date:  2003-04       Impact factor: 8.860

6.  Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.

Authors:  A K Cheung; M J Sarnak; G Yan; J T Dwyer; R J Heyka; M V Rocco; B P Teehan; A S Levey
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

7.  Design and statistical issues of the hemodialysis (HEMO) study.

Authors:  T Greene; G J Beck; J J Gassman; F A Gotch; J W Kusek; A S Levey; N W Levin; G Schulman; G Eknoyan
Journal:  Control Clin Trials       Date:  2000-10

8.  Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.

Authors:  Maurizio Postorino; Carmen Marino; Giovanni Tripepi; Carmine Zoccali
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094

9.  Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.

Authors:  Alfred K Cheung; Mark J Sarnak; Guofen Yan; Michael Berkoben; Robert Heyka; Allen Kaufman; Julia Lewis; Michael Rocco; Robert Toto; David Windus; Daniel Ornt; Andrew S Levey
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

10.  Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study.

Authors:  Kevin C Abbott; Christopher W Glanton; Fernando C Trespalacios; David K Oliver; Maria I Ortiz; Lawrence Y Agodoa; David F Cruess; Paul L Kimmel
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

View more
  58 in total

1.  The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Elani Streja; Csaba P Kovesdy; Antigone Oreopoulos; Nazanin Noori; Jennie Jing; Allen R Nissenson; Mahesh Krishnan; Joel D Kopple; Rajnish Mehrotra; Stefan D Anker
Journal:  Mayo Clin Proc       Date:  2010-11       Impact factor: 7.616

Review 2.  Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field.

Authors:  Natasha Dave; Jiao Wu; Sandhya Thomas
Journal:  Curr Diab Rep       Date:  2018-06-08       Impact factor: 4.810

3.  Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis.

Authors:  Piyawan Kittiskulnam; Glenn M Chertow; Juan J Carrero; Cynthia Delgado; George A Kaysen; Kirsten L Johansen
Journal:  Kidney Int       Date:  2017-03-17       Impact factor: 10.612

4.  Exercise as an Adjunct Therapy In Chronic Kidney Disease.

Authors:  Danielle L Kirkman; David G Edwards; Shannon Lennon-Edwards
Journal:  Renal Nutr Forum       Date:  2014

5.  Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis.

Authors:  Kamyar Kalantar-Zadeh; Elani Streja; Miklos Z Molnar; Lilia R Lukowsky; Mahesh Krishnan; Csaba P Kovesdy; Sander Greenland
Journal:  Am J Epidemiol       Date:  2012-03-16       Impact factor: 4.897

6.  Lean Body Mass and Survival in Hemodialysis Patients and the Roles of Race and Ethnicity.

Authors:  Jialin Wang; Elani Streja; Connie M Rhee; Melissa Soohoo; Mingliang Feng; Steven M Brunelli; Csaba P Kovesdy; Daniel Gillen; Kamyar Kalantar-Zadeh; Joline L T Chen
Journal:  J Ren Nutr       Date:  2015-10-21       Impact factor: 3.655

7.  Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.

Authors:  Garland A Campbell; James T Patrie; Bruce D Gaylinn; Michael O Thorner; Warren K Bolton
Journal:  Nephrol Dial Transplant       Date:  2018-03-01       Impact factor: 5.992

8.  Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.

Authors:  Connie M Rhee; Danh V Nguyen; Hamid Moradi; Steven M Brunelli; Ramanath Dukkipati; Jennie Jing; Tracy Nakata; Csaba P Kovesdy; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2015-03-29       Impact factor: 8.860

Review 9.  Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism.

Authors:  Bradley S Gordon; Jennifer L Steiner; David L Williamson; Charles H Lang; Scot R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-17       Impact factor: 4.310

Review 10.  Obesity paradox in end-stage kidney disease patients.

Authors:  Jongha Park; Seyed-Foad Ahmadi; Elani Streja; Miklos Z Molnar; Katherine M Flegal; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Prog Cardiovasc Dis       Date:  2013-10-09       Impact factor: 8.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.